blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2350044

EP2350044 - METHOD OF INDUCING NEGATIVE CHEMOTAXIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.12.2013
Database last updated on 18.11.2024
Most recent event   Tooltip13.12.2013Application deemed to be withdrawnpublished on 15.01.2014  [2014/03]
Applicant(s)For all designated states
Celtaxsys, Inc.
ATDC Biosciences Center, 0390
311 Ferst Drive
Atlanta, GA 30332 / US
[N/P]
Former [2011/31]For all designated states
Celtaxsys, INC.
ATDC Biosciences Center, 0390 311 Ferst Drive
Atlanta, GA 30332 / US
Inventor(s)01 / GOODHEW, Erica, Brook
2073 Hatteras Way
Atlanta GA 30318 / US
 [2011/31]
Representative(s)Chapman, Paul William
Kilburn & Strode LLP
20 Red Lion Street
London
WC1R 4PJ / GB
[N/P]
Former [2011/31]Chapman, Paul William
Kilburn & Strode LLP 20 Red Lion Street London
WC1R 4PJ / GB
Application number, filing date09819926.809.10.2009
[2011/31]
WO2009US60108
Priority number, dateUS20080104551P10.10.2008         Original published format: US 104551 P
[2011/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010042785
Date:15.04.2010
Language:EN
[2010/15]
Type: A1 Application with search report 
No.:EP2350044
Date:03.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.04.2010 takes the place of the publication of the European patent application.
[2011/31]
Search report(s)International search report - published on:US15.04.2010
(Supplementary) European search report - dispatched on:EP07.05.2012
ClassificationIPC:C07D401/00, A61K31/4184, A61K31/422, A61K31/4245, A61K31/428, A61K31/437, A61K31/506
[2012/18]
CPC:
A61K31/506 (EP,US); A61K31/4184 (EP,US); A61K31/422 (EP,US);
A61K31/4245 (EP,US); A61K31/427 (EP,US); A61K31/428 (EP,US);
A61K31/437 (EP,US); A61K31/501 (EP,US); A61P29/00 (EP) (-)
Former IPC [2011/31]C07D401/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/31]
TitleGerman:VERFAHREN ZUR EINLEITUNG VON NEGATIVER CHEMOTAXIS[2011/31]
English:METHOD OF INDUCING NEGATIVE CHEMOTAXIS[2011/31]
French:PROCÉDÉ D INDUCTION D UN CHIMIOTACTISME NÉGATIF[2011/31]
Entry into regional phase09.05.2011National basic fee paid 
09.05.2011Search fee paid 
09.05.2011Designation fee(s) paid 
09.05.2011Examination fee paid 
Examination procedure09.05.2011Examination requested  [2011/31]
03.12.2012Amendment by applicant (claims and/or description)
09.01.2013Despatch of a communication from the examining division (Time limit: M06)
20.07.2013Application deemed to be withdrawn, date of legal effect  [2014/03]
23.08.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/03]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.01.2013
Fees paidRenewal fee
25.10.2011Renewal fee patent year 03
25.10.2012Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.10.201305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - ISOMOTO HAJIME ET AL, "Immune and inflammatory responses in GERD and lansoprazole", JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, (200709), vol. 41, no. 2, ISSN 0912-0009, pages 84 - 91, XP002670913 [X] 1-8,12,14,15 * abstract and page 89, paragraph entitled "Conclusions" *

DOI:   http://dx.doi.org/10.3164/jcbn.2007012
 [X]  - CAPODICASA E ET AL, "Effect of lansoprazole on human leukocyte function", IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, INFORMA HEALTHCARE, US, (19990501), vol. 21, no. 2, ISSN 0892-3973, pages 357 - 377, XP009156930 [X] 1-8,12,14,15,18 * figure 3 and 4; page 374 *

DOI:   http://dx.doi.org/10.3109/08923979909052768
 [A]  - FABRIZIO VIANELLO ET AL, "Fugetaxis: active movement of leukocytes away from a chemokinetic agent", JOURNAL OF MOLECULAR MEDICINE, SPRINGER, BERLIN, DE, (20051001), vol. 83, no. 10, doi:10.1007/S00109-005-0675-Z, ISSN 1432-1440, pages 752 - 763, XP019320287 [A] 1-8,12-19 * abstract; page 757-758 *

DOI:   http://dx.doi.org/10.1007/s00109-005-0675-z
International search[Y]US2008213319  (KANG HYUN [US], et al);
 [Y]US5554631  (KIM SU UNG, et al);
 [Y]US5945425  (MOORMANN ALAN E [US], et al);
 [Y]US6184235  (CONNOR DAVID THOMAS [US], et al)
 [Y]  - WANDALL, "Effects of omeprazole on neutrophll chemotaxis, super oxide production, degranulation and translocation of cytochrome b-245", GUT, (1992), vol. 33, pages 617 - 621, XP008147621

DOI:   http://dx.doi.org/10.1136/gut.33.5.617
Examination   - HANDA O ET AL, "Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors", INFLAMMATION RESEARCH ; OFFICIAL JOURNAL OF: THE INTERNATIONAL ASSOCIATION OF INFLAMMATION SOCIETIES THE EUROPEAN HISTAMINE RESEARCH SOCIETY, BIRKHÄUSER-VERLAG, BA, (20061101), vol. 55, no. 11, doi:10.1007/S00011-006-6056-4, ISSN 1420-908X, pages 476 - 480, XP019452412

DOI:   http://dx.doi.org/10.1007/s00011-006-6056-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.